Un estudio retrospectivo de la eficacia de los inhibidores JAK o abatacept en la enfermedad pulmonar intersticial en artritis reumatoide
Inflammopharmacology. 2022. Epub ahead of print doi: 10.1007/s10787-022-00936-w
This study of the effectiveness of JAKinibs or abatacept in patients with RA-interstitial lung disease (RA-ILD) shows that treatment is related to stability or improvement of RA-ILD in over 80% of patients.